Leap Property Plant And Equipment Gross from 2010 to 2025

LPTX Stock  USD 0.48  0.01  2.04%   
Leap Therapeutics Property Plant And Equipment Gross yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Gross will likely drop to about 464.4 K in 2025. During the period from 2010 to 2025, Leap Therapeutics Property Plant And Equipment Gross regression line of annual values had r-squared of  0.18 and arithmetic mean of  418,240. View All Fundamentals
 
Property Plant And Equipment Gross  
First Reported
2013-03-31
Previous Quarter
475 K
Current Value
370 K
Quarterly Volatility
349.3 K
 
Yuan Drop
 
Covid
Check Leap Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Leap Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 336.9 K, Interest Expense of 4.3 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 110, Dividend Yield of 0.0025 or PTB Ratio of 1.41. Leap financial statements analysis is a perfect complement when working with Leap Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Leap Therapeutics Correlation against competitors.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.

Latest Leap Therapeutics' Property Plant And Equipment Gross Growth Pattern

Below is the plot of the Property Plant And Equipment Gross of Leap Therapeutics over the last few years. It is Leap Therapeutics' Property Plant And Equipment Gross historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Leap Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Gross10 Years Trend
Slightly volatile
   Property Plant And Equipment Gross   
       Timeline  

Leap Property Plant And Equipment Gross Regression Statistics

Arithmetic Mean418,240
Geometric Mean344,000
Coefficient Of Variation62.77
Mean Deviation191,865
Median451,000
Standard Deviation262,540
Sample Variance68.9B
Range1.1M
R-Value0.43
Mean Square Error60.3B
R-Squared0.18
Significance0.1
Slope23,633
Total Sum of Squares1T

Leap Property Plant And Equipment Gross History

2025464.4 K
2024555.5 K
2023483 K
2022689 K
2021495 K
2020593 K
20191.1 M

About Leap Therapeutics Financial Statements

Leap Therapeutics investors use historical fundamental indicators, such as Leap Therapeutics' Property Plant And Equipment Gross, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Leap Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Gross555.5 K464.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Leap Stock Analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.